Voxeleron

Pleasanton, United States Founded: 2010 • Age: 16 yrs
Retinal imaging solutions are developed for neurodegenerative diseases.

About Voxeleron

Voxeleron is a Healthcare company based in Pleasanton (United States) founded in 2010. Retinal imaging solutions are developed for neurodegenerative diseases. The company has 2 employees. Voxeleron offers products and services including iNEBULA and Orion. Its focus areas include Life Sciences, Neurology, In-Vitro Diagnostics and Neurodegenerative. Its legal entity is VOXELERON LLC. Its competitors include Rune Labs, Amprion and Durin Technologies; 3 of its 3 listed competitors have raised funding.

Company details

Voxeleron was founded in 2010 and is based in Pleasanton, United States. Retinal imaging software is developed by the company for applications in neurodegenerative diseases. The Orion product segments seven retinal layers in optical coherence tomography images and is compatible with common OCT scanners. It is intended for research use to identify biomarkers for conditions such as Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, and multiple sclerosis.

  • Headquarters Pleasanton, United States
  • Employees 2
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website voxeleron.com
  • Social LinkedIn X
  • Legal Name Voxeleron Llc
Key Metrics
  • Latest Funding Round
    $1.62M (USD), Grant

    Feb 2017

  • Investors
  • Employee Count
    2

Products & Services of Voxeleron

Voxeleron offers a comprehensive portfolio of products and services, including iNEBULA and Orion.

iNEBULA
Clinical Trial Platform

Platform for sharing and analyzing ophthalmic image data in trials.

Orion
Image Analysis Tool

Tool for AI-driven evaluation of ophthalmic images in research.

Funding Insights of Voxeleron

  • Total Rounds 1
  • Last Round Grant β€” $1.62M
  • First Round $1.62M

    (Feb 2017)

  • Investors Count 1

All 1 funding rounds of Voxeleron with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2017$1.62MGrant––
Valuation history

1 investors in total: 1 institutional.

Investors in Voxeleron

Voxeleron has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Voxeleron

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Voxeleron

2 people are tracked at Voxeleron (1 in leadership, 1 in team); the tracked headcount is 2.

NameRoleGroup
Jonathan Oakley
FounderLeadership
Nicolas Medina Sánchez
Lead Software System EngineerTeam
Premium access

Complete people profiles for Voxeleron

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Voxeleron

2 dated milestones of Voxeleron across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Voxeleron is founded.
  2. Funding First funding round of $1.6M.

Competitors of Voxeleron

Voxeleron has 3 listed competitors in our database, 3 of them funded. They include Rune Labs, Amprion and Durin Technologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
runelabs.io2018San Francisco, United States$56.51M35
Therapy management is enabled via a neuromodulation data platform.
ampriondx.com2006Houston, United States$11.76M34
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
durintechnologies.com2010Camden, United States$8.05M
Developer of the diagnostic test for neurodegenerative diseases
Premium access

Detailed competitors of Voxeleron

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Voxeleron

The website of Voxeleron (voxeleron.com) receives about 1.6K visits a month.

  • Monthly visits
    1.6K

    ▲ 23.1% vs previous month

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Voxeleron (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Voxeleron

Premium access

Complete news archive for Voxeleron

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Voxeleron

Voxeleron was founded in 2010 and raised its 1st funding round 7 years after it was founded.

Voxeleron is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.

Voxeleron has 2 employees.

Voxeleron was founded in 2010 and is based in Pleasanton, United States. Retinal imaging software is developed by the company for applications in neurodegenerative diseases. The Orion product segments seven retinal layers in optical coherence tomography images and is compatible with common OCT scanners. It is intended for research use to identify biomarkers for conditions such as Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, and multiple sclerosis.

Voxeleron's top competitors include Rune Labs, Amprion and Durin Technologies.

Voxeleron offers iNEBULA and Orion.

Voxeleron has 1 investor. Key investors include HHS.

Voxeleron operates through Voxeleron Llc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available